C

Cellectis SA
D

CLLS

1.66000
USD
-0.03
(-1.78%)
مغلق
حجم التداول
3,002
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
166,155,829
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALLO
    -0.17000
    (-8.19%)
    1.90500 USD
    B
    BEAM
    -2.140
    (-7.49%)
    26.440 USD
    B
    BLUE
    -0.51500
    (-5.75%)
    8.44000 USD
    C
    CRSP
    -3.490
    (-7.83%)
    41.110 USD
    E
    EDIT
    -0.17500
    (-11.51%)
    1.34500 USD
    F
    FATE
    -0.20000
    (-10.64%)
    1.68000 USD
    GILD
    GILD
    -2.130
    (-2.30%)
    90.630 USD
    N
    NTLA
    -1.110
    (-8.45%)
    12.020 USD
    VRTX
    VRTX
    -21.90
    (-4.67%)
    447.46 USD
    المزيد
الأخبار

العنوان: Cellectis SA

القطاع: Healthcare
الصناعة: Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.